Impact Factor

2.6

Global Health & Medicine -> 2023 Vol.5(No.4)

Editorial
Four decades of continuing innovations in the development of antiretroviral therapy for HIV/AIDS: Progress to date and future challenges
Global Health & Medicine. 2023; 5(4):194-198.
Review
Biology of the hepatitis B virus (HBV) core and capsid assembly modulators (CAMs) for chronic hepatitis B (CHB) cure
Global Health & Medicine. 2023; 5(4):199-207.
Current status of and future perspectives on care for cancer survivors in China
Global Health & Medicine. 2023; 5(4):208-215.
Original Article
Steady-state pharmacokinetics of plasma tenofovir alafenamide (TAF), tenofovir (TFV) and emtricitabine (FTC), and intracellular TFVdiphosphate and FTC-triphosphate in HIV-1 infected old Japanese patients treated with bictegravir/FTC/TAF
Global Health & Medicine. 2023; 5(4):216-222.
The reverse shock index multiplied by the Glasgow Coma Scale score can predict the need for initial resuscitation in patients suspected of sepsis
Global Health & Medicine. 2023; 5(4):223-228.
Construction of a risk index system for the prediction of chronic postsurgical pain after video-assisted thoracic surgery for lung resection: A modified Delphi study
Global Health & Medicine. 2023; 5(4):229-237.
Brief Report
Economic burden of cancer attributable to modifiable risk factors in Japan
Global Health & Medicine. 2023; 5(4):238-245.
Commentary
Sorafenib and surgery for hepatocellular carcinoma – a controversial relation: Lesson learned?
Global Health & Medicine. 2023; 5(4):246-248.
Correspondence
International cooperation for nursing human resource development in Lao PDR: Investing in nursing leadership
Global Health & Medicine. 2023; 5(4):249-254.
Letter
Underlying background of the current trend of increasing HPV vaccination coverage in Japan
Global Health & Medicine. 2023; 5(4):255-256.